MERRIMACK PHARMACEUTICALS INC Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MERRIMACK PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MERRIMACK PHARMACEUTICALS INC for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24 2015 | MACK | MERRIMACK PHARMACE ... | Nielsen Ulrik B. | Director | Option Exercise | M | 1.71 | 12,023 | 20,559 | 0 | |
| Feb 24 2015 | MACK | MERRIMACK PHARMACE ... | Nielsen Ulrik B. | Director | Option Exercise | M | 1.71 | 7,977 | 13,641 | 75,000 | |
| Feb 24 2015 | MACK | MERRIMACK PHARMACE ... | Nielsen Ulrik B. | Director | Sell | S | 10.91 | 20,000 | 218,200 | 226,811 | 246.8 K to 226.8 K (-8.10 %) |
| Feb 24 2015 | MACK | MERRIMACK PHARMACE ... | Nielsen Ulrik B. | Director | Buy | M | 1.71 | 12,023 | 20,559 | 246,811 | 234.8 K to 246.8 K (+5.12 %) |
| Feb 24 2015 | MACK | MERRIMACK PHARMACE ... | Nielsen Ulrik B. | Director | Buy | M | 1.71 | 7,977 | 13,641 | 234,788 | 226.8 K to 234.8 K (+3.52 %) |
| Feb 20 2015 | MACK | MERRIMACK PHARMACE ... | Mulroy Robert J. | President and CEO | Option Exercise | M | 1.71 | 150,000 | 256,500 | 306,753 | |
| Feb 20 2015 | MACK | MERRIMACK PHARMACE ... | Mulroy Robert J. | President and CEO | Sell | S | 10.94 | 150,000 | 1,641,000 | 1,339,316 | 1.5 M to 1.3 M (-10.07 %) |
| Feb 20 2015 | MACK | MERRIMACK PHARMACE ... | Mulroy Robert J. | President and CEO | Buy | M | 1.71 | 150,000 | 256,500 | 1,489,316 | 1.3 M to 1.5 M (+11.20 %) |
| Feb 19 2015 | MACK | MERRIMACK PHARMACE ... | Stewart Edward J. | SVP & Pres, Healthc ... | Option Exercise | M | 1.81 | 6,000 | 10,860 | 85,000 | |
| Feb 19 2015 | MACK | MERRIMACK PHARMACE ... | Stewart Edward J. | SVP & Pres, Healthc ... | Sell | S | 10.31 | 6,000 | 61,860 | 21,385 | 27.4 K to 21.4 K (-21.91 %) |
| Feb 19 2015 | MACK | MERRIMACK PHARMACE ... | Stewart Edward J. | SVP & Pres, Healthc ... | Buy | M | 1.81 | 6,000 | 10,860 | 27,385 | 21.4 K to 27.4 K (+28.06 %) |
| Feb 11 2015 | MACK | MERRIMACK PHARMACE ... | Mulroy Robert J. | President and CEO | Option Exercise | A | 9.08 | 250,000 | 2,270,000 | 250,000 | |
| Feb 11 2015 | MACK | MERRIMACK PHARMACE ... | McClements William M. | SVP of Corporate Op ... | Option Exercise | A | 9.08 | 90,000 | 817,200 | 90,000 | |
| Feb 11 2015 | MACK | MERRIMACK PHARMACE ... | Sullivan William A. | CFO and Treasurer | Option Exercise | A | 9.08 | 90,000 | 817,200 | 90,000 | |
| Feb 11 2015 | MACK | MERRIMACK PHARMACE ... | Stewart Edward J. | SVP & Pres, Healthc ... | Option Exercise | A | 9.08 | 90,000 | 817,200 | 90,000 | |
| Feb 11 2015 | MACK | MERRIMACK PHARMACE ... | Laivins Peter N | SVP of Development | Option Exercise | A | 9.08 | 150,000 | 1,362,000 | 150,000 | |
| Feb 11 2015 | MACK | MERRIMACK PHARMACE ... | Schoeberl Birgit M. | Head of Discovery | Option Exercise | A | 9.08 | 125,000 | 1,135,000 | 125,000 |